Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Metagenomi, Inc.

Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Tickers KALV MGX
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Announces New Appointment to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Participate in Upcoming Investor Conferences
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Tickers MGX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.